As the peak activity of cell-mediated anti-tumor immune response in mice occurs within 1 to 2 weeks32,33, a timeframe consistent with tumor rejection in Cav-2 KO mice, it is very likely that host deficiency in Cav-2 enhances the anti-tumor immune response. Here, CAV2 is linked to neoplasm.